Starling Oncology, Inc. Deferred Income Tax Liabilities, Net
Starling Oncology, Inc. (STLN) had Deferred Income Tax Liabilities, Net of $0 as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-03-12
- 2025-12-31: Deferred Income Tax Liabilities, Net $0.00.
- 2025-09-30: Deferred Income Tax Liabilities, Net $0.00.
- 2025-06-30: Deferred Income Tax Liabilities, Net $0.00.
- 2025-03-31: Deferred Income Tax Liabilities, Net $32.00K.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 |
| 2025-03-31 | $32.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $32.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $32.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $32.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $32.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $32.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $158.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $78.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $82.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $108.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $554.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $502.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $551.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $371.00K 10-K · filed 2023-03-16 |
| 2020-12-31 | $1.61M 10-K · filed 2022-03-11 |